Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Malignant Melanoma

  Free Subscription


Articles published in Ophthalmology

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    July 2020
  1. JOUHI S, Heikkonen J, Reijonen V, Raivio V, et al
    BRACHYTHERAPY OF CHOROIDAL MELANOMAS LESS THAN 10 MM IN LARGEST BASAL DIAMETER Comparison of 10-mm and 15-mm Ruthenium Plaques.
    Ophthalmology. 2020 Jul 7. pii: S0161-6420(20)30628.
    PubMed     Abstract available


    June 2020
  2. ESPENSEN CA, Kiilgaard JF, Appelt AL, Fog LS, et al
    Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanomas.
    Ophthalmology. 2020 Jun 20. pii: S0161-6420(20)30572.
    PubMed     Abstract available


    May 2020
  3. BOGAARD J, Czaja R, Wirostko WJ
    Metastatic Choroidal Melanoma Treated with Ipilimimab.
    Ophthalmology. 2020;127:600.
    PubMed    


    April 2020
  4. CHUANG K, Vortmeyer A, Liu S
    Conjunctival Fungal Ball Mimicking Melanoma.
    Ophthalmology. 2020;127:534.
    PubMed    


  5. JAMPOL LM, Moy CS, Murray TG, Reynolds SM, et al
    The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19.
    Ophthalmology. 2020;127.
    PubMed     Abstract available


  6. SALOWE R, O'Brien JM
    The Collaborative Ocular Melanoma Study Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma.
    Ophthalmology. 2020;127.
    PubMed    


    January 2020
  7. MANTA A, Goldberg RA
    Pembrolizumab-Related Enophthalmos.
    Ophthalmology. 2020;127:121.
    PubMed    


    November 2019
  8. ABDEL-RAHMAN MH, Sample KM, Pilarski R, Walsh T, et al
    Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
    Ophthalmology. 2019 Nov 18. pii: S0161-6420(19)32274.
    PubMed     Abstract available


  9. LI J, Seider MI
    Pseudomelanoma: Spontaneous Myopic Choroidal Hemorrhage.
    Ophthalmology. 2019;126:1491.
    PubMed    


    October 2019
  10. VAN IPENBURG JA, Gillis Ing AJM, Dorssers LCJ, van den Bosch QCC, et al
    MicroRNA Profiling in Benign and Malignant Conjunctival Melanocytic Lesions.
    Ophthalmology. 2019 Oct 12. pii: S0161-6420(19)32142.
    PubMed    


    September 2019
  11. FRANCIS JH, Berry D, Abramson DH, Barker CA, et al
    Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading.
    Ophthalmology. 2019 Sep 24. pii: S0161-6420(19)32085.
    PubMed     Abstract available


    April 2019
  12. VICHITVEJPAISAL P, Dalvin LA, Mazloumi M, Ewens KG, et al
    Genetic Analysis of Uveal Melanoma in 658 Patients using The Cancer Genome Atlas (TCGA) Classification of Uveal Melanoma as A, B, C & D.
    Ophthalmology. 2019 Apr 23. pii: S0161-6420(19)30611.
    PubMed     Abstract available


  13. GROSSNIKLAUS HE
    Understanding Uveal Melanoma Metastasis to the Liver: The Zimmerman Effect and the Zimmerman Hypothesis.
    Ophthalmology. 2019;126:483-487.
    PubMed    


  14. ABRAMSON DH, Francis JH
    Pseudomelanoma (with Cataract) in a Child Caused by Amniocentesis.
    Ophthalmology. 2019;126:590.
    PubMed    


    December 2018
  15. MUDHAR HS, Doherty RE, Salvi SM, Currie ZI, et al
    Genetic Profiling of Primary Orbital Melanoma-An Analysis of 6 Cases with Clinico-Pathological Correlation.
    Ophthalmology. 2018 Dec 31. pii: S0161-6420(18)32892.
    PubMed    


  16. PAPUDESU C, Reddy SG, Potter HD
    Ocular Metastasis of Cutaneous BRAF Wild-Type Melanoma.
    Ophthalmology. 2018;125:1966.
    PubMed    


    November 2018
  17. SCHOLZ SL, Murali R, Westekemper H, Schadendorf D, et al
    Re: van Poppelen et al.: Genetic background of iris melanomas and iris melanocytic tumors of uncertain malignant potential (Ophthalmology. 2018;125:904-912).
    Ophthalmology. 2018;125:e78-e79.
    PubMed    


  18. BEVER GJ, Seider MI
    Two-Toned Lipofuscin in the Same Choroidal Melanoma: Orange versus Gray.
    Ophthalmology. 2018;125:1792.
    PubMed    


    August 2018
  19. JAGER MJ, Brouwer NJ, Esmaeli B
    The Cancer Genome Atlas Project: An Integrated Molecular View of Uveal Melanoma.
    Ophthalmology. 2018;125:1139-1142.
    PubMed    


    July 2018
  20. ROELOFS K, Puttagunta L, Weis E
    Choroidal Melanoma with Overlying Lipofuscin Sediment.
    Ophthalmology. 2018;125:1053.
    PubMed    


    May 2018
  21. DAMATO B
    Predicting Choroidal Melanoma Regression after Brachytherapy.
    Ophthalmology. 2018;125:755-756.
    PubMed    


  22. MICIELI JA, Newman NJ, Biousse V
    Retinal Imaging of an Optic Tract Lesion: OCT Angiography of Structural and Functional Defects.
    Ophthalmology. 2018;125:756.
    PubMed    


    April 2018
  23. BAGGER M, Smidt-Nielsen I, Andersen MK, Jensen PK, et al
    Long-Term Metastatic Risk after Biopsy of Posterior Uveal Melanoma.
    Ophthalmology. 2018 Apr 25. pii: S0161-6420(17)33868.
    PubMed     Abstract available


  24. AFSHAR AR, Damato BE, Stewart JM, Heimann H, et al
    Re: Reddy et al.: Vitrectomy and vitrector port needle biopsy of choroidal melanoma for gene expression profile testing immediately before brachytherapy. (Ophthalmology. 2017;124:1377-1382).
    Ophthalmology. 2018;125:e28-e29.
    PubMed    


  25. RAMAKRISHNAN M, Vora R, Seider MI
    Oculodermal Melanocytosis, Darker Complexion, Choroidal Melanoma: A Missed Clue.
    Ophthalmology. 2018;125:494.
    PubMed    


    February 2018
  26. RASHID M, Heikkonen J, Singh AD, Kivela TT, et al
    Clinical Predictors of Regression of Choroidal Melanomas after Brachytherapy: A Growth Curve Model.
    Ophthalmology. 2018 Feb 27. pii: S0161-6420(17)33252.
    PubMed     Abstract available


    January 2018
  27. VAN POPPELEN NM, Vaarwater J, Mudhar HS, Sisley K, et al
    Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    Ophthalmology. 2018 Jan 19. pii: S0161-6420(17)32844.
    PubMed     Abstract available


  28. SHIELDS CL, Di Nicola M, Bekerman VP, Kaliki S, et al
    Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
    Ophthalmology. 2018 Jan 13. pii: S0161-6420(17)32069.
    PubMed     Abstract available


    November 2017
  29. THARIAT J, Rahmi A, Salleron J, Mosci C, et al
    Proton Beam Therapy for Iris Melanomas in 107 Patients.
    Ophthalmology. 2017 Nov 8. pii: S0161-6420(17)32582.
    PubMed     Abstract available


  30. LIAO A, Mittal P, Lawson DH, Yang JJ, et al
    Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver.
    Ophthalmology. 2017 Nov 6. pii: S0161-6420(17)32368.
    PubMed     Abstract available


    October 2017
  31. AYRES B, Elner V, Demirci H
    Massive Extraocular Extension of Choroidal Melanoma after Brachytherapy.
    Ophthalmology. 2017;124:1503.
    PubMed    


    September 2017
  32. VALSECCHI ME, Orloff M, Sato R, Chervoneva I, et al
    Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.
    Ophthalmology. 2017 Sep 18. pii: S0161-6420(17)30329.
    PubMed     Abstract available


    August 2017
  33. SZALAI E, Wells JR, Ward L, Grossniklaus HE, et al
    Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Ophthalmology. 2017 Aug 17. pii: S0161-6420(17)31332.
    PubMed     Abstract available


    June 2017
  34. WALTER SD, Cummings TJ, Mruthyunjaya P
    Anterior Chamber Angle Invasion of Iridociliary Melanoma.
    Ophthalmology. 2017;124:842.
    PubMed    


    May 2017
  35. MRUTHYUNJAYA P, Seider MI, Stinnett S, Schefler A, et al
    Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.
    Ophthalmology. 2017 May 23. pii: S0161-6420(16)31873.
    PubMed     Abstract available


  36. SHIELDS CL, Say EAT, Hasanreisoglu M, Saktanasate J, et al
    Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture.
    Ophthalmology. 2017 May 7. pii: S0161-6420(17)30398.
    PubMed     Abstract available


  37. PELLEGRINI M, Staurenghi G
    Swept-source Optical Coherence Tomography Angiography Imaging in a Case of Uveal Melanoma.
    Ophthalmology. 2017;124:729.
    PubMed    


    April 2017
  38. REDDY DM, Mason LB, Mason JO 3rd, Crosson JN, et al
    Vitrectomy and Vitrector Port Needle Biopsy of Choroidal Melanoma for Gene Expression Profile Testing Immediately before Brachytherapy.
    Ophthalmology. 2017 Apr 28. pii: S0161-6420(16)32000.
    PubMed     Abstract available


  39. MOKHTARZADEH A, Harrison AR, Maltry AC
    Malignant Orbital Melanoma Associated with Oculodermal Melanocytosis.
    Ophthalmology. 2017;124:561.
    PubMed    


  40. CHAUGULE SS, Finger PT
    Regression Patterns of Iris Melanoma after Palladium-103 (103Pd) Plaque Brachytherapy.
    Ophthalmology. 2017 Apr 1. pii: S0161-6420(17)30011.
    PubMed     Abstract available


    January 2017
  41. SHIELDS CL, Say EA, Hasanreisoglu M, Saktanasate J, et al
    Cytogenetic Abnormalities in Uveal Melanoma Based on Tumor Features and Size in 1059 Patients: The 2016 W. Richard Green Lecture.
    Ophthalmology. 2017 Jan 31. pii: S0161-6420(16)31846.
    PubMed     Abstract available


    December 2016
  42. JACINTO FA, Margo CE
    Neglected Choroidal Melanoma Tracking Along Optic Nerve to Brain.
    Ophthalmology. 2016;123:2488.
    PubMed    


  43. YAVUZYIGITOGLU S, Drabarek W, Smit KN, van Poppelen N, et al
    Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma.
    Ophthalmology. 2016 Dec 1. pii: S0161-6420(16)31717.
    PubMed    


    November 2016
  44. SKALET AH, Li Y, Lu CD, Jia Y, et al
    Optical Coherence Tomography Angiography Characteristics of Iris Melanocytic Tumors.
    Ophthalmology. 2016 Nov 14. pii: S0161-6420(16)31328.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: